ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
09 Sep 2020

Acarix announces preliminary outcome in oversubscribed rights issue

Press release Malmö, Sweden September 9, 2020 Acarix announces preliminary outcome in oversubscribed rights issue INSIDE INFORMA...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
15 Jul 2020

Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK

Pressmeddelande Malmö, Sverige, 15 juli 2020 Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK Styrels...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
15 Jul 2020

Acarix decides on a guaranteed rights issue of approximately SEK 56 million

Press release Malmö, Sweden July 15, 2020 Acarix decides on a guaranteed rights issue of approximately SEK 56 million The board ...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
30 Oct 2019

Acarix announce final outcome in rights issue

Press release Malmö, 30 October 2019Inside informationAcarix ABAcarix announce final outcome in rights issueAcarix AB ("Acarix" or...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
30 Oct 2019

Acarix offentliggör slutgiltigt utfall i företrädesemission

Pressmeddelande  Malmö, 30 oktober 2019InsiderinformationAcarix ABAcarix offentliggör slutgiltigt utfall i för...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
09 Oct 2019

Idag inleds teckningsperioden i Acarix företrädesemission

Pressmeddelande  Malmö, 9 oktober 2019Idag inleds teckningsperioden i Acarix företrädesemissionStyrelsen i Acarix A...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
09 Oct 2019

The subscription period in Acarix’ rights issue commence today

Press releaseMalmö, 9 October 2019The subscription period in Acarix' rights issue commence todayThe board of directors of Acarix A...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
25 Sep 2019

Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpansion

Pressmeddelande  Malmö, 25 september 2019Acarix genomför företrädesemission om cirka 51,8 MSEK för att fi...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
25 Sep 2019

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Press release  Malmö, 25 September 2019Acarix carries out a rights issue of approximately SEK 51.8 million to finance an incr...
Continue reading
  • 1
  • 2
  • 3
  • 4
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.